Skip to main content

Gene therapy developer Gyroscope Technologies raises $60.6M

Gyroscope earlier this year merged with Montgomery County-based Orbit Biomedical in a union of gene therapy companies focuses on developing new treatments for retinal disease.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.